Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 2/20 | 0.31 |
| ▸ | CNR2 | P34972 | 2/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10045201 | 0.76 | ALDH1A1 (0.41) | FAAHALDH1A1KDM4ESMN1; SMN2MAPT | |
| SCHEMBL21164656 | 0.76 | KDM4E (0.41) | FAAHALDH1A1KDM4EGAATSHR | |
| SCHEMBL18948819 | 0.75 | EPHX1 (0.42) | FAAHALDH1A1TSHRMAPTTRPV1 | |
| SCHEMBL8764497 | 0.74 | ZDHHC20 (0.44) | FAAHALDH1A1GAAHPGDTSHR | |
| SCHEMBL18867143 | 0.73 | ADH1B (0.39) | ALDH1A1GAATSHRCNR1HRH3 | |
| SCHEMBL23682848 | 0.71 | ALDH1A1 (0.42) | ALDH1A1HRH3 | |
| SCHEMBL19069143 | 0.71 | ALDH1A1 (0.39) | ALDH1A1TSHRHRH3 | |
| SCHEMBL18948738 | 0.70 | ADH1B (0.43) | FAAHALDH1A1TSHRMAPTTRPV1 | |
| SCHEMBL11410139 | 0.69 | ALDH1A1 (0.37) | ALDH1A1MAPT | |
| SCHEMBL18867159 | 0.68 | ADH1B (0.44) | FAAHALDH1A1TSHRMAPTTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351883-B2 | Compounds for increasing lipid synthesis and storage | NUTECH VENTURES (US) | 2019-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351883-B2 | Compounds for increasing lipid synthesis and storage | FASN, LIPC, SREBF2 | FAAH 561/4885ALDH1A1 1121/4885KDM4E 1755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.